Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 9,134,580 | 9,155,712 | 9,075,348 | 9,180,246 | 8,111,192 |
| Cost of Goods | 1,970,000 | 1,869,000 | 1,884,000 | 2,136,190 | 1,821,560 |
| Gross Profit | 7,051,000 | 7,310,000 | 7,210,000 | 7,183,969 | 6,989,630 |
| Operating Expenses | 4,186,000 | 4,207,000 | 4,337,000 | 4,883,109 | 4,219,160 |
| Operating Income | 2,978,580 | 3,079,712 | 2,854,348 | 2,161,137 | 2,071,032 |
| Interest Expense | 110,000 | 87,000 | 79,000 | 74,340 | 74,150 |
| Other Income | -133,580 | -36,712 | 124,652 | -90,427 | 679,038 |
| Pre-tax Income | 2,735,000 | 2,956,000 | 2,900,000 | 1,996,370 | 2,675,920 |
| Income Tax | 751,000 | 814,000 | 797,000 | 543,110 | 736,680 |
| Net Income Continuous | 1,938,300 | 2,091,856 | 2,054,484 | 1,546,542 | 1,890,876 |
| Net Income | $1,938,300 | $2,091,856 | $2,054,484 | $1,546,542 | $1,890,876 |
| EPS Basic Total Ops | 0.85 | 0.90 | 0.89 | 0.66 | 0.81 |
| EPS Basic Continuous Ops | 0.85 | 0.90 | 0.89 | 0.66 | 0.81 |
| EPS Diluted Total Ops | 0.85 | 0.90 | 0.89 | 0.66 | 0.81 |
| EPS Diluted Continuous Ops | 0.85 | 0.90 | 0.89 | 0.66 | 0.81 |
| EBITDA(a) | $2,978,580 | $3,079,712 | $2,854,348 | $2,161,137 | $2,071,032 |